在过敏性鼻炎中,Arctigenin通过KLF5/BIRC3/NFκB轴缓解炎症,并通过KLF5/BIRC3/NFκB轴重塑鼻上皮质屏障功能
Lili Xu1, Yujuan An1, Ting Liu2
1Department of Pharmacy Intravenous Admixture Services, Qingdao Traditional Chinese Medicine Hospital, Qingdao Hiser Hospital Affiliated of Qingdao University, Qingdao 266033, Shandong, PR China.
Toxicology and applied pharmacology
|August 13, 2025
概括
阿尔基基宁 (ATG) 通过改善鼻屏障功能和减少炎症,有效治疗过敏性鼻炎 (AR). 它通过抑制KLF5蛋白,BIRC3转录和NF-κB通路而起作用,为AR提供了一种新的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 过敏性鼻炎 (AR) 是一个普遍存在的全球健康问题,需要先进的治疗策略.
- 了解AR背后的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 研究阿尔基基宁 (ATG) 在缓解过敏性鼻炎中的治疗机制.
- 阐明KLF5,BIRC3和NF-κB通路在ATG抗AR作用中的作用.
主要方法:
- 对过敏性鼻炎小鼠模型的构建和使用ATG或德克萨米的治疗.
- 在体外研究中,使用人鼻上皮细胞 (HNEpC) 用IL-4和IL-13刺激.
- 生物信息分析,晶状病毒介导的基因操纵 (KLF5过度表达,BIRC3淘汰) 和NF-κB通路激活.
主要成果:
- 在AR小鼠和HNEpCs中,Arctigenin (ATG) 在改造鼻上皮屏障和减少炎症方面表现出有效性.
- ATG抑制了KLF5蛋白表达,该蛋白通过转录激活BIRC3和NF-κB通路.
- KLF5的过度表达加剧了AR症状,而BIRC3的淘汰扭转了这些影响;NF-κB通路的激活加剧了炎症损伤.
结论:
- 阿尔基基宁 (ATG) 通过抑制KLF5蛋白表达来改善过敏性鼻炎,从而抑制BIRC3转录并损害NF-κB信号通路.
- ATG的机制涉及恢复鼻上皮质屏障功能和减少炎症,为AR提供了一个有希望的治疗途径.
相关概念视频
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
Antiasthma Drugs: Leukotriene Modifiers
470
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
470
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
459
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
459
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.3K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
Drugs Used in Lower Respiratory Disorders: Overview
583
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
583
Inflammatory Response
7.2K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.2K


